CE VIDEO - Great Masqueraders: Systemic Conditions with Ocular Complications
Julie Tyler, OD
March 22, 2021
March 7, 2024
Estimated time to complete activity:
Computer System Requirements:
Access to internet and a web browser is required to complete this activity.
This one hour lecture will discuss systemic conditions with ocular complications that a primary eye care practitioner may encounter in a practice setting.
After completing this activity, the participant should be better able to:
- Review some of the various secondary ocular findings and risks that can occur following infections with “masquerader” infections.
- Recognize potential complications of syphilis and Lyme infection in the anterior segment and posterior segment of the eye and supplement an exam with appropriate specific questioning and general observations of the patient.
- Discuss appropriate treatment options, including topical agents for short term management of anterior segment findings, while pursuing appropriate testing, referral, and oral management of underlying systemic disease.
- Identify presentations that may require further imaging or referral due to potential systemic or neurologic complications or associations.
This activity is intended for optometrists who provide primary care optometry services, including but not limited to medical optometric services.
Julie Tyler, OD
Continuing Education Credit:
This activity, COPE Activity Number 121327is accredited by COPE for continuing education for optometrists. This course is COPE approved for 1 hour of CE credit. Course ID is 71721-SD. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.
Reviewed by :
Disclosure of Conflicts of Interest:
Review Education Group (REG) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to REG policy. REG is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Dr. Tyler has nothing to disclose
Method of Participation Request for Credit:
During the period March 22, 2021 through March 7, 2024 participants must read the learning objectives, faculty disclosures and view the complete educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation at the conclusion of this course. Post course tests must receive a score of 70% or better in order for a certificate of completion to be issued.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.